Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review

March 2021 | 95 pages | ID: TAC5A58E78DEN
GlobalData

Abstracts

Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teva Pharmaceutical Industries Ltd (Teva) discovers, develops, manufactures and commercializes generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, women’s health and other therapy areas. The company offers generic medicines in a range of dosage forms including capsules, tablets, injectables, liquids, inhalants, creams and ointments. Teva also provides over-the-counter (OTC) products, besides active pharmaceutical ingredients (APIs). It is currently focusing on developing new generic drugs. The company conducts its worldwide operations through a network of global subsidiaries. Teva is headquartered in Petach Tikva, Israel.

Teva Pharmaceutical Industries Ltd Key Recent Developments

Mar 01,2021: Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference
Feb 10,2021: Teva reports fourth quarter and full year 2020 financial results
Feb 03,2021: Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals
Jan 27,2021: Teva takes data-driven decision-making to next level with Genedata Biologics
Jan 12,2021: Teva sets ambitious long-term environmental goals as part of renewed ESG Strategy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Teva Pharmaceutical Industries Ltd - Key Facts
Teva Pharmaceutical Industries Ltd - Key Employees
Teva Pharmaceutical Industries Ltd - Key Employee Biographies
Teva Pharmaceutical Industries Ltd - Major Products and Services
Teva Pharmaceutical Industries Ltd - History
Teva Pharmaceutical Industries Ltd - Company Statement
Teva Pharmaceutical Industries Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Teva Pharmaceutical Industries Ltd - Business Description
Geographical Segment: Europe
Target Markets
Performance
Overview
Geographical Segment: International Markets
Target Markets
Performance
Geographical Segment: North America
Target Markets
Performance
Overview
R&D Overview
Teva Pharmaceutical Industries Ltd - Corporate Strategy
Teva Pharmaceutical Industries Ltd - SWOT Analysis
SWOT Analysis - Overview
Teva Pharmaceutical Industries Ltd - Strengths
Teva Pharmaceutical Industries Ltd - Weaknesses
Teva Pharmaceutical Industries Ltd - Opportunities
Teva Pharmaceutical Industries Ltd - Threats
Teva Pharmaceutical Industries Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 01, 2021: Teva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance Conference
Feb 10, 2021: Teva reports fourth quarter and full year 2020 financial results
Jan 27, 2021: Teva takes data-driven decision-making to next level with Genedata Biologics
Jan 12, 2021: Teva sets ambitious long-term environmental goals as part of renewed ESG Strategy
Nov 05, 2020: Teva reports third quarter 2020 financial results
Aug 25, 2020: Statement in response to news of the Indictment of Teva USA
Aug 05, 2020: Teva enters biosimilar commercialisation partnership with Alvotech
Aug 05, 2020: Teva reports second quarter 2020 financial results
Aug 04, 2020: Teva Pharmaceutical Industries announces board change
Jul 31, 2020: Teva-Takeda joint venture divests certain assets in Japan to Nichi-Iko

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Teva Pharmaceutical Industries Ltd, Key Facts
Teva Pharmaceutical Industries Ltd, Key Employees
Teva Pharmaceutical Industries Ltd, Key Employee Biographies
Teva Pharmaceutical Industries Ltd, Major Products and Services
Teva Pharmaceutical Industries Ltd, History
Teva Pharmaceutical Industries Ltd, Subsidiaries
Teva Pharmaceutical Industries Ltd, Joint Venture
Teva Pharmaceutical Industries Ltd, Key Competitors
Teva Pharmaceutical Industries Ltd, Ratios based on current share price
Teva Pharmaceutical Industries Ltd, Annual Ratios
Teva Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
Teva Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
Teva Pharmaceutical Industries Ltd, Interim Ratios
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Teva Pharmaceutical Industries Ltd, Performance Chart (2016 - 2020)
Teva Pharmaceutical Industries Ltd, Ratio Charts
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Teva Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021